Prevalence of parkinsonism and Parkinson's disease in the Arosa Island (Spain): A community-based door-to-door survey

Journal of the Neurological Sciences

Volumn 304, Issue 1-2, 2011, Pages 49-54

  Seijo Martinez, M ^a   Castro Del Rio, M ^b   Rodriguez Alvarez J ^b   Suarez Prado, R ^c   Torres Salgado, E ^c   Paz Esquete, J ^d   Sobrido, M J ^e  

^a Neurology   (Spain)

^b Complexo Hospitalario de Pontevedra ^*  (Spain)

^c Primary Care Unit   (Spain)

^d Preventive Medicine   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Elderly; Epidemiology; Parkinson's disease; Parkinsonism; Population isolate; Prevalence; Survey

Indexed keywords

CLEBOPRIDE; FLUNARIZINE; LEVODOPA; METOCLOPRAMIDE; NEUROLEPTIC AGENT; RISPERIDONE; SULPIRIDE; THIORIDAZINE;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG INDUCED PARKINSONISM; ENVIRONMENTAL FACTOR; EUROPE; FEMALE; GROUPS BY AGE; HEALTH CARE SYSTEM; HEREDITY; HUMAN; MALE; MENTAL DISEASE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PARKINSONISM; PARKINSONISM WITH ASSOCIATED FEATURES; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SENESCENCE; SPAIN; UNSPECIFIED PARKINSONISM; VASCULAR PARKINSONISM;

AGED; AGED, 80 AND OVER; DATA COLLECTION; FEMALE; HEALTH SURVEYS; HUMANS; MALE; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PREVALENCE; SPAIN;

EID: 79953320391     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2011.02.015     Document Type: Article

References (29)

1. Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease. N Engl J Med 2003;348:1356-64. (Pubitemid 36384104)
2. Zhang ZX, Román GC. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 1993;12:195-208. (Pubitemid 23353338)
3. Morgante L, Rocca WA, Di Rosa AE, De Domenico P, Grigoletto F, Meneghini F, et al. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) group. Neurology 1992;42:1901-7.
4. Tison F, Dartigues JF, Dubes L, Zuber M, Alperovitch A, Henry P. Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France. Acta Neurol Scand 1994;90:111-5. (Pubitemid 24261206)
5. de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology 1995;45:2143-6. (Pubitemid 27100237)
6. De Rijk MC, Tzourio C, Breteler MM, Dartigues JF, Amaducci L, Lopez-Pousa S, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON collaborative study. J Neurol Neurosurg Psychiatry 1997;62:10-5. (Pubitemid 27047434)
7. Melcon MO, Anderson DW, Vergara RH, Rocca WA. Prevalence of Parkinson's disease in Junín, Buenos Aires Province, Argentina. Mov Disord 1997;12:197-205. (Pubitemid 27152024)
8. de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, et al. Prevalence of Parkinson's disease in Europe: a collaborative study of populationbased cohorts. Neurology 2000;54(Suppl 5):S21-3.
9. Wang SJ, Fuh JL, Teng EL, Liu CY, Lin KP, Chen HM, et al. A door-to-door survey of Parkinson's disease in a Chinese population in Kinmen. Arch Neurol 1996;53:66-71. (Pubitemid 26023286)
10. Clavería LE, Duarte J, Sevillano MD, Pérez-Sempere A, Cabezas C, Rodríguez F, et al. Prevalence of Parkinson's disease in Cantalejo, Spain: a door-to-door survey. Mov Disord 2002;17:242-9.
11. Benito-León J, Bermejo-Pareja F, Rodríguez J, Molina JA, Gabriel R, Morales JM, et al. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord 2003;18:267-74. (Pubitemid 36410822)
12. Bermejo FP, Gabriel RS, Vega SQ, Morales JM, Rocca WA, Anderson DW. Problems and issues with door-to-door, two-phase surveys: an illustration from central Spain. Neuroepidemiology 2001;20:225-31. (Pubitemid 34701950)
13. Maggi S, Zucchetto M, Grigoletto F, Baldereschi M, Candelise L, Scarpini E, et al. The Italian Longitudinal Study on Aging (ILSA): design and methods. Aging (Milano) 1994;6:464-73.
14. Migliore L, Coppede F. Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat Res 2009;674:73-84.
15. Myles S, Tang K, Somel M, Green RE, Kelso J, Stoneking M. Identification and analysis of genomic regions with large between-population differentiation in humans. Ann Hum Genet 2008;72:99-110.
16. Shmulewitz D, Auerbach SB, Lehner T, Blundell ML, Winick JD, Youngman LD, et al. Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia. Hum Hered 2001;51:8-19.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised third edition.Washington, DC: American Psychiatric Association; 1987.
19. Louis ED, Bennett DA. Mild Parkinsonian signs: an overview of an emerging concept. Mov Disord 2007;22:1681-8. (Pubitemid 47597591)
20. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5:525-35. (Pubitemid 44262284)
21. Tanner CM, Hubble JP, Chan P. Epidemiology and genetics of Parkinson's disease. In: Watts RL, Koller WC, editors. Movement disorders. Neurological principles and practice. New York: McGraw-Hill; 1996. p. 137-52.
22. Wang YS, Shi YM, Wu ZY, He YX, Zhang BZ. Parkinson's disease in China. Coordinational Group of Neuroepidemiology, PLA. Chin Med J 1991;104:960-4.
23. Zhang ZX, Anderson DW, Huang JB, Li H, Hong X, Wei J, et al. Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China. Mov Disord 2003;18:764-72. (Pubitemid 36939971)
24. Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, Eshuis S, et al. Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:819-24. (Pubitemid 47204585)
25. Alves G, Müller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, et al. Incidence of Parkinson's disease in Norway: the Norwegian Park West study. J Neurol Neurosurg Psychiatry 2009;80:851-7.
26. Yacoubian TA, Howard G, Kissela B, Sands CD, Standaert DG. Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study. Neuroepidemiology 2009;33:329-34.
27. Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark TW, Frosch MP, et al. Effects of gender on nigral gene expression and parkinson disease. Neurobiol Dis 2007;26:606-14. (Pubitemid 46756328)
28. Saunders-Pullman R. Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both? Endocrine 2003;21:81-7.
29. Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology 2010;34:143-51.